Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapy

Medicine & Life Sciences

• Simvastatin 81%
• Hydroxymethylglutaryl-CoA Reductase Inhibitors 66%
• Type 2 Diabetes Mellitus 51%
• Muscles 41%
• Ubiquinone 30%
• Citrate (si)-Synthase 30%
• Energy Metabolism 20%
• Genes 18%
• Muscle Mitochondrion 16%
• Dermatomyositis 14%
• Myalgia 12%
• Quadriceps Muscle 12%
• Muscular Diseases 12%
• Creatine Kinase 11%
• LDL Lipoproteins 11%
• Therapeutics 11%
• Oxidoreductases 10%
• Extracellular Matrix 9%
• Skeletal Muscle 9%
• Blood Platelets 8%
• Biopsy 6%
• Gene Expression 6%
• Polymerase Chain Reaction 6%
• Blood Vessels 6%
• Safety 6%
• Serum 5%

Social Sciences

• chronic illness 67%
• expenditures 60%
• blood samples 48%
• energy 46%
• human being 35%
• withdrawal 32%
• tolerance 31%
• evidence 28%
• event 19%

Chemical Compounds

• Simvastatin 100%
• Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor 98%
• Metabolic 55%
• Coenzyme 24%
• Creatine 14%
• Low-Density Lipoprotein 13%
• Microarrays 12%
• Chain Reaction 11%
• Energy 10%
• Safety 9%
• Biosynthesis 9%
• Reduction 5%